Hound Partners’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-298,515
Closed -$2.98M 178
2021
Q3
$2.98M Hold
298,515
0.16% 39
2021
Q2
$2.98M Sell
298,515
-1,485
-0.5% -$14.8K 0.14% 43
2021
Q1
$2.97M Buy
+300,000
New +$3.04M 0.14% 47

Other funds holding EQHA.U

Hound Partners's EQHA.U Position: Q4 2021 in Review

Hound Partners sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2021, closing a stake of 298,515 shares — an estimated $2.98M sold.

Hound Partners first reported a position in EQHA.U in Q1 2021 and held it in 3 quarters. The position peaked at $2.98M in Q3 2021. 23 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2021.

  • Hound Partners reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Hound Partners sold 298,515 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2021, an estimated $2.98M.
  • Hound Partners first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Hound Partners's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $2.98M in Q3 2021.
  • 23 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2021.

Based on Hound Partners's 13F filing for Q4 2021, filed 14 Feb 2022.